2 These were huge developments in the space, according to Dr
Under this approach, most patients receiving stable maintenance therapy who do not report notable gastrointestinal symptoms may safely continue treatment before elective procedures
Oral Routes and Dosing Profiles GLP-1 medications exist in multiple formulations, each with distinct pharmacokinetic profiles and dosing schedules
A., Presta, L
UK product information advises that patients should: Recognise symptoms of pancreatitis (severe, persistent abdominal pain radiating to the back, nausea, vomiting) Seek immediate medical attention if these symptoms develop Discontinue the medicine if pancreatitis is suspected Not restart the GLP-1 medicine if pancreatitis is confirmed Patients should also be aware of an increased risk of gallbladder disease (gallstones, cholecystitis) with GLP-1 medicines, which can present with similar abdominal symptoms and requires prompt medical attention
Tuy nhin, nu chm ch s dng u n thng xuyn th mi ngi vn c th nhn thy s thay i dn dn trn ln da ca mnh